Skip to Main Content
Table 2.

Baseline TBSE practice in the year before test reporting and in the past 5 y, as well as changes in absolute and relative TBSE intentions compared with baseline following genetic test reporting and counseling, in each group and in the total sample

Carriers
Noncarriers
Total sample (N = 58)
CDKN2A/p16+ no melanoma history (n = 14)CDKN2A/p16+ melanoma history (n = 18)CDKN2A/p16 no melanoma history (n = 26*)
Baseline TBSEs     
    Participants who received a TBSE in the past year at baseline, n (%) 3 (21.4) 14 (77.8) 13 (50) 30 (51.7) 
    Average no. TBSEs in the past 5 y 2.57 4.78 1.98 2.99 
    No TBSEs in the past 5 y at baseline, n (%)     
    0 TBSEs 3 (21.4) 1 (5.6) 2 (7.7) 6 (10.3) 
    1 or 2 TBSEs 5 (35.7) 3 (16.7) 19 (73.1) 27 (46.6) 
    3 or 4 TBSEs 3 (21.4) 3 (16.7) 3 (11.5) 9 (15.5) 
    5 or 6 TBSEs 2 (14.3) 4 (22.2) 1 (3.8) 7 (12.1) 
    >6 TBSEs 1 (7.1) 7 (38.9) 1 (3.8) 9 (15.5) 
     
Postcounseling TBSE Intentions     
    Participants intending to receive a TBSE in the next year,97 100 65 83.1 
    Intended TBSEs in future relative to current practice§ 4.29 3.33 3.52 3.64 
Carriers
Noncarriers
Total sample (N = 58)
CDKN2A/p16+ no melanoma history (n = 14)CDKN2A/p16+ melanoma history (n = 18)CDKN2A/p16 no melanoma history (n = 26*)
Baseline TBSEs     
    Participants who received a TBSE in the past year at baseline, n (%) 3 (21.4) 14 (77.8) 13 (50) 30 (51.7) 
    Average no. TBSEs in the past 5 y 2.57 4.78 1.98 2.99 
    No TBSEs in the past 5 y at baseline, n (%)     
    0 TBSEs 3 (21.4) 1 (5.6) 2 (7.7) 6 (10.3) 
    1 or 2 TBSEs 5 (35.7) 3 (16.7) 19 (73.1) 27 (46.6) 
    3 or 4 TBSEs 3 (21.4) 3 (16.7) 3 (11.5) 9 (15.5) 
    5 or 6 TBSEs 2 (14.3) 4 (22.2) 1 (3.8) 7 (12.1) 
    >6 TBSEs 1 (7.1) 7 (38.9) 1 (3.8) 9 (15.5) 
     
Postcounseling TBSE Intentions     
    Participants intending to receive a TBSE in the next year,97 100 65 83.1 
    Intended TBSEs in future relative to current practice§ 4.29 3.33 3.52 3.64 

NOTE: Values in boldface indicate significant differences from baseline.

*

One CDKN2A/p16 participant provided incomplete baseline data. As a result, the sample size in this group varies depending on which screening measure is considered.

Values of 1 were given to participants who indicated that they intended to obtain a TBSE in the next year, whereas values of 0.5 were given to participants who answered “maybe.”

P < 0.001.

§

1, much less than I have been doing; 5, much more than I have been doing. Boldfaced values indicate that the group mean was significantly >3.0 (“about the same as I have been doing”) and thus represents a significant intention to increase TBSEs relative to current practice.

P < 0.05.

P < 0.01.

Close Modal

or Create an Account

Close Modal
Close Modal